Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 9 studies | 25% ± 7% | |
epithelial cell | 5 studies | 29% ± 10% | |
endothelial cell | 4 studies | 21% ± 6% | |
classical monocyte | 3 studies | 19% ± 4% | |
astrocyte | 3 studies | 31% ± 8% | |
dendritic cell | 3 studies | 27% ± 8% | |
basal cell | 3 studies | 27% ± 9% | |
goblet cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4716.23 | 258 / 258 | 100% | 26.25 | 230 / 230 |
esophagus | 100% | 3300.19 | 1445 / 1445 | 100% | 24.08 | 183 / 183 |
liver | 100% | 2776.23 | 226 / 226 | 100% | 23.62 | 406 / 406 |
ovary | 100% | 3918.51 | 180 / 180 | 100% | 33.99 | 430 / 430 |
pancreas | 100% | 2648.97 | 328 / 328 | 100% | 30.32 | 178 / 178 |
prostate | 100% | 5281.67 | 245 / 245 | 100% | 38.13 | 502 / 502 |
skin | 100% | 4040.06 | 1809 / 1809 | 100% | 39.58 | 472 / 472 |
stomach | 100% | 3015.83 | 359 / 359 | 100% | 32.45 | 286 / 286 |
thymus | 100% | 4956.27 | 653 / 653 | 100% | 38.20 | 605 / 605 |
uterus | 100% | 3900.74 | 170 / 170 | 100% | 35.12 | 459 / 459 |
lung | 100% | 3599.77 | 578 / 578 | 100% | 29.68 | 1154 / 1155 |
brain | 100% | 2658.55 | 2637 / 2642 | 100% | 27.55 | 705 / 705 |
bladder | 100% | 3446.00 | 21 / 21 | 100% | 36.58 | 503 / 504 |
kidney | 100% | 3546.33 | 89 / 89 | 100% | 25.27 | 899 / 901 |
breast | 100% | 3619.07 | 459 / 459 | 100% | 30.72 | 1113 / 1118 |
intestine | 100% | 3486.01 | 966 / 966 | 99% | 35.26 | 524 / 527 |
adipose | 100% | 3261.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 36.72 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.63 | 29 / 29 |
spleen | 100% | 5417.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.38 | 1 / 1 |
blood vessel | 100% | 3156.96 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3347.94 | 916 / 929 | 0% | 0 | 0 / 0 |
muscle | 98% | 1454.89 | 790 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1529.68 | 847 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015786 | Biological process | UDP-glucose transmembrane transport |
GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0036066 | Biological process | protein O-linked fucosylation |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0005801 | Cellular component | cis-Golgi network |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0015297 | Molecular function | antiporter activity |
Gene name | SLC35C2 |
Protein name | Solute carrier family 35 member C2 Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein) |
Synonyms | OVCOV1 CGI-15 C20orf5 |
Description | FUNCTION: May play an important role in the cellular response to tissue hypoxia. May be either a GDP-fucose transporter that competes with SLC35C1 for GDP-fucose, or a factor that otherwise enhances the fucosylation of Notch and is required for optimal Notch signaling in mammalian cells. . |
Accessions | Q5JW04 Q5JW03 ENST00000543605.5 [Q9NQQ7-2] ENST00000243896.6 [Q9NQQ7-1] ENST00000317734.12 [Q9NQQ7-3] ENST00000372230.10 [Q9NQQ7-1] ENST00000424568.1 ENST00000372227.5 [Q9NQQ7-1] Q9NQQ7 ENST00000420518.5 |